Home Compliance DOJ Reaches Settlement with OraPharma, Inc., Pushing Novel AKS Theory ComplianceExpert OpinionFCANews DOJ Reaches Settlement with OraPharma, Inc., Pushing Novel AKS Theory March 1, 2023 32 Share FacebookLinkedinTwitter Mr.Music | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Expert Opinion The Next Frontier: Key Takeaways from the New U.S. Government Commercial Space Strategies Compliance Not an April Fools Joke – FAR Part 40 Final Rule Has Been Published Compliance DOJ’s First Intervention in Cybersecurity FCA Qui Tam Case Signals Continued Cyber Enforcement